MBZUAI Professor Fakherddine Karray is developing deep learning algorithms for human activity recognition to monitor the health and safety of elderly people. The AI tools analyze movement, posture, and facial expressions to detect early warning signs of health emergencies. Remote patient monitoring systems integrate smart devices and secure communication to allow elderly patients to stay at home and communicate with healthcare providers. Why it matters: AI-powered smart homes can provide affordable healthcare solutions for the rapidly growing elderly population in the region and worldwide.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.
MBZUAI researchers developed ClinGRAD, a multimodal graph neural network that analyzes genomic data, MRI scans, and clinical information to classify dementia types (Alzheimer's, vascular, etc.). The system addresses the challenge of high misdiagnosis rates (up to 30%) in dementia, where incorrect diagnoses can significantly impact patient life expectancy. ClinGRAD aims to be an interpretable AI system, providing explainability to clinicians. Why it matters: Accurate and early diagnosis of dementia subtypes is crucial for slowing disease progression and improving patient care in the region, where the prevalence of dementia is expected to rise significantly.
KAUST researchers, in collaboration with the Salk Institute and Altos Labs, have identified a class of RNA (LINE-1) that, when compromised, leads to accelerated aging, as seen in progeria. They devised an antisense RNA strategy to block the aberrant function of L1 RNA, reversing the disease in mice and patient-derived cells. Published in Science Translational Medicine, the research suggests that targeting LINE-1 RNA could treat progeroid syndromes and other age-related diseases. Why it matters: This RNA-based approach provides a potential therapeutic avenue for treating premature aging diseases and extending human health span in the region and globally.
KAUST has launched the Center of Excellence for Smart Health (KCSH), chaired by Professor Imed Gallouzi and co-chaired by Professor Xin Gao. The center aims to develop smart-health technologies, integrating AI, machine learning, and other disciplines to address health challenges. KCSH will collaborate with partners across Saudi Arabia to focus on personalized diagnosis, treatment, and prevention of diseases. Why it matters: This initiative addresses the evolving healthcare needs of Saudi Arabia's aging population and high prevalence of genetic diseases, positioning the Kingdom as a leader in smart health solutions.
The article discusses the potential of AI-enabled assistive technologies to empower People with Disabilities (PWD), citing that over one billion people live with some form of disability globally. It highlights examples like communication tools, assistive robots, and smart visual aids, and emphasizes the need to address security and privacy concerns. The author, Ishfaq Ahmad from the University of Texas at Arlington, points out that with a growing global population, over two billion people will need assistive products by 2030. Why it matters: The piece advocates for using AI to tackle critical human rights issues and improve the lives of a significant portion of the global population in the face of increasing disability rates.
KAUST researchers are exploring the link between nutrition and brain-energy metabolism to address cognitive decline, dementia, and Alzheimer’s disease. Dr. Pierre Magistretti and Dr. Johannes le Coutre are collaborating on ways to merge brain-energy metabolism research into the field of nutrition. They published an article entitled “Goals in Nutrition Science 2015-2020” in the journal Frontiers in Nutrition. Why it matters: This research could lead to nutritional interventions to hinder or prevent cognitive decline, offering a new approach beyond traditional drug treatments.
Two mothers in the UAE have created an AI-powered teddy bear named "Emar" designed to help neurodivergent children communicate. Emar uses sensors and machine learning to analyze a child's emotional state through voice and touch. The AI then provides feedback and suggests coping mechanisms to both the child and their parents. Why it matters: This innovative application of AI offers a novel approach to supporting neurodivergent children and their families in the UAE.